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ABSTRACT 
 
Neurotropic arboviruses are leading causative agents of viral encephalitis 
worldwide.  These pathogens specifically infect neurons to cause acute encephalitic 
disease and permanent neurological sequelae in humans, which are particularly severe in 
the pediatric population.  Pathogenesis of neurotropic arboviruses correlates with the 
degree of neuronal maturity in the host, and populations of neural stem/progenitor cells 
demonstrate particular susceptibility to viral infection.  However, the mechanism(s) by 
which defense against a neurotropic arbovirus increases with human neuronal 
development have yet to be fully dissected.  To investigate changes in neuronal innate 
immune function over the course of development, we established a model for the in vitro 
derivation of enriched populations of human neural progenitor cells (NPCs) and mature 
human neurons from human embryonic stem cells (hESCs).  Using the hESC model in 
conjunction with primary cortical rat neurons and human neuronal cells, we identified 
novel maturation-dependent changes in the neuronal type I interferon (IFN) signaling 
pathway, including upregulation of the IFN-α/β receptor 2 subunit (IFNAR2) on the cell 
surface of mature neurons.  Furthermore, we determined that basal upregulation of 
IFNAR2 is sufficient for increased type I IFN-dependent inhibition of neurotropic 
arbovirus replication.  Finally, we dissected a downstream mechanism by which type I 
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IFN mediates its antiviral activity by identifying MxA as a functional inhibitor of 
neurotropic arbovirus replication in human neuronal cells.  Together our data demonstrate 
that the innate antiviral immune function of a human neuron increases with 
differentiation, resulting in enhanced defense against neurotropic arbovirus infection.  
Our careful dissection of maturation-dependent changes in the neuronal type I IFN 
signaling pathway in vitro paves the way for future investigations, which will determine 
the impact of neuron-specific innate immune function on global host defense against 
neurotropic arboviruses in vivo. 
 
